Bulk N-Glycyl-L-Tyrosine for Lyophilized Injectables
Residual Moisture Limits and Glass Transition Temperature Control in Freeze-Dried N-Glycyl-L-tyrosine Formulations
In the lyophilization of parenteral formulations containing N-Glycyl-L-tyrosine, precise control of residual moisture is critical to prevent cake collapse and ensure long-term stability. Our field experience indicates that the amorphous nature of this dipeptide, when freeze-dried with common bulking agents, can lead to a depressed glass transition temperature (Tg') if moisture levels exceed 2%. This is particularly relevant when scaling up from lab to production, where variations in dryer load and shelf temperature gradients can introduce micro-collapses not visible to the naked eye but detectable by increased reconstitution times. A non-standard parameter we monitor is the shift in Tg' when residual moisture fluctuates between 0.5% and 1.5%—a range where the cake appears intact but the molecular mobility is sufficient to accelerate degradation of the phenolic hydroxyl group. For procurement managers, specifying a loss-on-drying limit of ≤1.0% in the COA is a practical safeguard, but we recommend requesting batch-specific data on moisture distribution within a lyophilized cake, as edge effects in bulk trays can create localized high-moisture zones. This hands-on knowledge stems from troubleshooting multiple scale-up runs where identical Karl Fischer averages masked significant intra-batch variability.
Excipient Compatibility: Mannitol vs. Sucrose Buffering Effects on Phenolic Hydroxyl Stability
The choice of bulking agent in a lyophilized injectable containing N-Glycyl-L-tyrosine directly impacts the chemical stability of the dipeptide, particularly the oxidation-prone phenolic moiety. Mannitol, a common crystalline excipient, provides an elegant cake structure but offers minimal hydrogen-bonding stabilization to the tyrosine hydroxyl group. In contrast, sucrose, as an amorphous stabilizer, can form a glassy matrix that restricts molecular mobility and reduces oxidation rates. However, our internal studies reveal a subtle pH drift phenomenon: residual acidity from sucrose degradation products (e.g., glucose and fructose formed during autoclaving) can lower the microenvironmental pH, potentially catalyzing the hydrolysis of the glycyl-tyrosine peptide bond. This is a non-standard parameter often overlooked in excipient compatibility screening. For a drop-in replacement strategy, we recommend a mannitol-sucrose blend (typically 4:1 w/w) to balance cake rigidity and stabilization, while monitoring the pH of the reconstituted solution over 24 hours at 25°C. This approach has been validated in multiple customer formulations where the original Alfa Aesar product was used, ensuring seamless substitution without reformulation. For further insights into solvent selection and racemization control during peptide synthesis, refer to our detailed guide on sourcing H-Gly-Tyr-Oh for SPPS with a focus on racemization control and solvent selection.
COA Parameters for Peroxide Limits to Prevent Yellowing in Lyophilized Injectables
Yellowing of lyophilized N-Glycyl-L-tyrosine cakes is a common stability issue that procurement managers must address through rigorous COA specifications. The primary culprit is oxidative degradation of the phenolic ring, often catalyzed by trace peroxides in excipients or residual solvents. While standard COAs may not include peroxide limits, we strongly recommend requesting a peroxide value (PV) of ≤5 ppm for the bulk dipeptide, as determined by a ferrous oxidation-xylenol orange (FOX) assay. In our experience, batches with PV above 10 ppm exhibit noticeable yellowing within 6 months at 25°C/60% RH, even when stored under nitrogen. A non-standard parameter we track is the initial color of the powder before lyophilization; a slight off-white hue (APHA >50) can indicate early-stage oxidation that will amplify during freeze-drying. For drop-in replacement, ensure that the supplier's N-Glycyl-L-tyrosine matches the peroxide profile of the legacy Alfa Aesar material. Below is a comparison of typical COA parameters for parenteral-grade N-Glycyl-L-tyrosine from different sources:
| Parameter | Typical Specification (Parenteral Grade) | Our Drop-in Replacement |
|---|---|---|
| Assay (HPLC) | ≥98.0% | ≥99.0% |
| Loss on Drying | ≤1.0% | ≤0.5% |
| Heavy Metals (as Pb) | ≤10 ppm | ≤5 ppm |
| Peroxide Value | Not routinely reported | ≤5 ppm (FOX assay) |
| Residual Solvents | Meets USP <467> | Class 3 only, <0.5% |
These enhanced specifications ensure that our N-Glycyl-L-tyrosine performs as a true drop-in replacement, minimizing the risk of reformulation. For a broader discussion on sourcing strategies, including solvent control, see our article on поиск H-Gly-Tyr-Oh для SPPS с контролем рацемизации и выбором растворителя.
Bulk Packaging and Supply Chain Integrity for Parenteral-Grade N-Glycyl-L-tyrosine
Maintaining the quality of bulk N-Glycyl-L-tyrosine from manufacturing to the point of use requires packaging that protects against moisture, oxygen, and physical damage. For parenteral-grade material, we supply the dipeptide in double polyethylene bags inside a sealed aluminum foil laminate bag, with desiccant, and packed in a fiber drum. This configuration is suitable for quantities up to 25 kg. For larger orders, we offer 210L drums with inner liners, ensuring minimal headspace and nitrogen flushing. A critical logistics consideration is the avoidance of temperature excursions during transport; while the dipeptide is stable at ambient temperatures, exposure to >40°C can accelerate degradation. We recommend including temperature loggers in shipments during summer months. Our supply chain is designed to provide batch-to-batch consistency, with full traceability from raw materials to finished product. As a global manufacturer, we maintain safety stock of key intermediates to ensure lead times of 4-6 weeks for bulk orders, mitigating the risk of production delays. The product is also available under its alternative names, such as Glycyl-L-tyrosine and Gly-Tyr-OH, to facilitate cross-referencing with existing specifications.
Frequently Asked Questions
What are the acceptable heavy metal thresholds for parenteral intermediates like N-Glycyl-L-tyrosine?
For parenteral-grade intermediates, the total heavy metals content (as lead) should not exceed 10 ppm, with individual metals like arsenic, cadmium, and mercury typically limited to ≤1 ppm each. Our N-Glycyl-L-tyrosine consistently meets a tighter specification of ≤5 ppm total heavy metals, as shown in the COA table above. This is critical because heavy metals can catalyze oxidative degradation of the peptide and pose patient safety risks. When sourcing, always request a detailed elemental impurities analysis per ICH Q3D guidelines.
How do loss-on-drying variations affect cake collapse during primary drying?
Loss-on-drying (LOD) directly correlates with the residual moisture content of the bulk powder before lyophilization. A higher LOD means more water is present, which can lower the glass transition temperature (Tg') of the formulation during freezing, leading to incomplete sublimation and potential cake collapse during primary drying. Even a 0.5% increase in LOD can shift the collapse temperature by 2-3°C, causing micro-collapse that reduces surface area and increases reconstitution time. We recommend an LOD of ≤0.5% for N-Glycyl-L-tyrosine intended for lyophilized injectables to provide a robust processing window.
What should you not mix with L-tyrosine?
While this question often refers to dietary supplements, in a pharmaceutical context, L-tyrosine and its dipeptides should not be mixed with strong oxidizing agents, as the phenolic hydroxyl group is susceptible to oxidation. In formulation, avoid excipients with high peroxide content (e.g., certain grades of PEG or polysorbates) unless peroxide levels are controlled. Additionally, avoid alkaline conditions (pH >8) during processing, as this can promote racemization and degradation of the peptide bond.
Can I dissolve L-tyrosine in water?
Free L-tyrosine has very low water solubility (about 0.45 mg/mL at 25°C), which limits its use in parenteral solutions. However, N-Glycyl-L-tyrosine is significantly more soluble due to the glycine moiety; we routinely achieve concentrations of ≥10.7 mg/mL in water, as noted in the product data. This enhanced solubility makes it a preferred form for lyophilized injectables, where reconstitution volume is critical.
What is L-tyrosine disodium salt dihydrate used for?
L-Tyrosine disodium salt dihydrate is a highly water-soluble form of tyrosine used in parenteral nutrition and as a precursor for neurotransmitter synthesis. It is often employed when high concentrations of tyrosine are needed in solution. However, N-Glycyl-L-tyrosine offers an alternative with potentially better stability and compatibility in certain formulations, as the peptide bond can protect the amino group from Maillard reactions with reducing sugars.
Is n-acetyl-L-tyrosine water soluble?
N-Acetyl-L-tyrosine has improved water solubility compared to free L-tyrosine, but it is still limited (approximately 2.4 mg/mL). In contrast, N-Glycyl-L-tyrosine provides superior solubility, making it a more versatile choice for high-concentration lyophilized injectables. The solubility advantage is a key factor when selecting a tyrosine source for parenteral formulations.
Sourcing and Technical Support
As a leading manufacturer of peptide building blocks, NINGBO INNO PHARMCHEM CO.,LTD. offers bulk N-Glycyl-L-tyrosine with the consistency and quality required for lyophilized injectables. Our product serves as a seamless drop-in replacement for legacy Alfa Aesar material, with enhanced COA parameters to address common stability challenges. We understand the nuances of excipient compatibility, pH drift, and peroxide control that can make or break a lyophilized formulation. For custom synthesis requirements or to validate our drop-in replacement data, consult with our process engineers directly.